After several tireless days we have finished crunching the numbers from nearly 900 13F filings issued by the elite hedge funds and other investment firms that we track at Insider Monkey, which ...
In recent trading, shares of Reata Pharmaceuticals Inc (Symbol: RETA) have crossed above the average analyst 12-month target price of $119.18, changing hands for $167.19/share. When a stock reaches ...
Singer RETA has ended her contract with rapper San E's agency following a home break-in incident. Reports claim an employee entered RETA's residence without permission while she was abroad, allegedly ...
In this article, I’m going to take a look at Reata Pharmaceuticals Inc’s (NASDAQ:RETA) latest ownership structure, a non-fundamental factor which is important, but remains a less discussed subject ...
Reata Pharmaceuticals, Inc. (NASDAQ:RETA) shareholders should be happy to see the share price up 26% in the last month. But that hardly compensates for the shocking decline over the last twelve months ...
Reata Pharmaceuticals Inc (NASDAQ:RETA) just announced data from an interim study of its lead blood pressure study, and they company has picked up a bit of strength on the back of the release. The ...
Famous Entertainment, the agency headed by rapper San E, is facing intense public scrutiny after singer RETA moved to legally terminate her exclusive contract, citing a disturbing incident involving ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results